Transthyretin Amyloidosis

Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study

The Eplontersen Pregnancy and Lactation Outcomes Study

Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, Turkey

HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

PL_GNT01_ISR_Grant 53234273

Transthyretin Amyloidosis Outcome Survey (THAOS)